Cost-benefit of limited isolation and testing in COVID-19 mitigation

被引:17
|
作者
Eilersen, Andreas [1 ]
Sneppen, Kim [1 ]
机构
[1] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark
基金
欧洲研究理事会;
关键词
SPREAD;
D O I
10.1038/s41598-020-75640-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The international community has been put in an unprecedented situation by the COVID-19 pandemic. Creating models to describe and quantify alternative mitigation strategies becomes increasingly urgent. In this study, we propose an agent-based model of disease transmission in a society divided into closely connected families, workplaces, and social groups. This allows us to discuss mitigation strategies, including targeted quarantine measures. We find that workplace and more diffuse social contacts are roughly equally important to disease spread, and that an effective lockdown must target both. We examine the cost-benefit of replacing a lockdown with tracing and quarantining contacts of the infected. Quarantine can contribute substantially to mitigation, even if it has short duration and is done within households. When reopening society, testing and quarantining is a strategy that is much cheaper in terms of lost workdays than a long lockdown. A targeted quarantine strategy is quite efficient with only 5 days of quarantine, and its effect increases when testing is more widespread.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Cost–benefit of limited isolation and testing in COVID-19 mitigation
    Andreas Eilersen
    Kim Sneppen
    Scientific Reports, 10
  • [2] COVID-19: Cost-Benefit Analysis and Politics
    Priel, Dan
    OSGOODE HALL LAW JOURNAL, 2020, 57 (03): : 537 - 565
  • [3] A cost-benefit analysis of the COVID-19 disease
    Rowthorn, Robert
    Maciejowski, Jan
    OXFORD REVIEW OF ECONOMIC POLICY, 2020, 36 : S38 - S55
  • [4] A cost-benefit analysis of COVID-19 lockdowns in Australia
    Lally, Martin
    MONASH BIOETHICS REVIEW, 2022, 40 (01) : 62 - 93
  • [5] A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia
    Lopez, Francesc
    Catala, Marti
    Prats, Clara
    Estrada, Oriol
    Oliva, Irene
    Prat, Nuria
    Isnard, Mar
    Valles, Roser
    Vilar, Marc
    Clotet, Bonaventura
    Argimon, Josep Maria
    Aran, Anna
    Ara, Jordi
    VACCINES, 2022, 10 (01)
  • [6] A social cost-benefit framework for COVID-19 policy decisions
    Heatley, Dave
    NEW ZEALAND ECONOMIC PAPERS, 2022, 56 (01) : 41 - 48
  • [7] Tracing and testing multiple generations of contacts to COVID-19 cases: cost-benefit trade-offs
    Kim, Jungyeol
    Chen, Xingran
    Nikpey, Hesam
    Rubin, Harvey
    Saeedi Bidokhti, Shirin
    Sarkar, Saswati
    ROYAL SOCIETY OPEN SCIENCE, 2022, 9 (10):
  • [8] A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona
    Lopez Segui, Francesc
    Estrada Cuxart, Oriol
    Mitja i Villar, Oriol
    Hernandez Guillamet, Guillem
    Prat Gil, Nuria
    Maria Bonet, Josep
    Isnard Blanchar, Mar
    Moreno Millan, Nemesio
    Blanco, Ignacio
    Vilar Capella, Marc
    Catala Sabate, Marti
    Aran Sole, Anna
    Argimon Pallas, Josep Maria
    Clotet, Bonaventura
    Ara del Rey, Jordi
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
  • [9] Cost-benefit analysis of the COVID-19 vaccination model incorporating different infectivity reductions
    Appiah, Raymond Fosu
    Jin, Zhen
    Yang, Junyuan
    Asamoah, Joshua Kiddy K.
    FRONTIERS IN PHYSICS, 2024, 12
  • [10] Cost-benefit analyses of radon mitigation projects
    Petersen, Mads Lyngby
    Larsen, Thommy
    JOURNAL OF ENVIRONMENTAL MANAGEMENT, 2006, 81 (01) : 19 - 26